• World - Asia
  • Updated: September 30, 2022

COVID-19: Indonesia Authorises First Domestic Vaccines

Indonesia has approved its first locally developed COVID-19 vaccine for emergency use.

The head of the country's public health agency said this on Friday, hailing it as a step toward "the nation's independence in access to medicine."

The head of the national food and drugs agency (BPOM) Penny Lukito stated; "The development of a domestic vaccine is a pride for us Indonesians as a foundation and as the first step to achieve the nation's independence in access to medicine."

The IndoVac jab, developed by state-owned pharmaceutical company Bio Farma and Texas-based Baylor College of Medicine, can now be used as a primary dose for an unvaccinated or partially vaccinated adult in the country.

The medical chief said IndoVac had shown an efficacy rate of 92%, while there were no reports of death linked to it in trials and reported side effects were "generally mild."

The homegrown IndoVac jab has been granted a halal certificate, meaning it can be administered in line with the Islamic faith in Muslim-majority Indonesia.


Join our Telegram platform to get news update Join Now
Quadri Adejumo
Quadri Adejumo

Quadri Adejumo is a reporter and a column writer. He covers news on World, Diaspora and Health.

More From this Author


neimeth international pharmaceuticals plc Health Care

Neimeth International Pharmaceutical Plc was founded in 1957. The company is th...

nigeria-german chemicals plc Health Care

Nigerian-German Chemicals Plc manufactures formerly known as Hoechst Products Ni...

glaxo smithkline consumer nig. plc Health Care

GlaxoSmithKline Consumer Nigeria Plc was incorporated in Nigeria on 23rd June 19...

evans medical plc Health Care

Evans Medical Plc is incorporated in Nigeria as a pharmaceutical manufacturing a...


0 Comment(s)


See this post in...